Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesions-Reference-Cited by-同舟云学术

Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesions

Published:1983-02 Issue:8 Volume:32 Page:871-878
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Chang Raymond S.L.,Lotti Victor J.,Martin Gregory E.,Chen Tsing B.

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference20 articles.

1. Neural Peptides and Neuronal Communication;Emson,1980

2. Evidence for coexistence of dopamine and CCK in meso-limbic neurones

3. A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracing

4. Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons

5. Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic Function;Drug Discovery and Evaluation: Pharmacological Assays;2016

2. Pancreatic Function;Drug Discovery and Evaluation: Pharmacological Assays;2014

3. Activity on the Gastrointestinal Tract;Drug Discovery and Evaluation;2007

4. Activity on the gastrointestinal tract1;Drug Discovery and Evaluation;2002

5. Cholecystokinin and Psychiatric Disorders;CNS Drugs;1997-08